Sonoma Biotherapeutics has emerged from stealth with $40m from investors including Lyell Immunopharma and is developing regulatory T-cell therapies for autoimmune and degenerative diseases.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Square, Ideo Colab Ventures and CMT Digital helped the financial settlement platform developer hike its overall funding to over $22m.

Grace Beauty Capital was among the investors in a round that lifted the military-grade personal care brand's total funding to almost $20m.

HKT, Telefónica, Singtel and Deutsche Telekom all contributed to the first round disclosed by telecoms payment platform developer Clear.

Azafaros, a metabolic disorder drug developer leveraging Leiden University and Amsterdam UMC inventions, has secured $28m in series A capital.

The UBC bioprinting spinout will use part of the funding to progress two of its projects towards commercialisation.

The University of Bristol-led incubator now has more than 80 portfolio companies, which posted a combined turnover of $77m during 2019.

Kakao Ventures co-led a round that also featured Baidu Ventures, LG Ventures and existing backer Samsung Next, taking the 3D collaboration platform developer's total funding to $22m.